Virginia Commonwealth University Massey Cancer Center


Virginia Commonwealth Commences Canakinumab Study Targeting Severe COVID-19 Patients with Pneumonia

Virginia Commonwealth University (VCU), a prominent public research university in Richmond, Virginia, became one of the first clinical investigational sites in the world to begin clinical trials to study the safety and efficacy of the Novartis drug canakinumab on...

Pin It on Pinterest